H5N1 Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Inactivated Influenza A/H5N1 Vaccine Administered Intradermally With or Without Topical Aldara in Healthy Young Adults
Conditions:   Avian Influenza;   Influenza Immunisation Interventions:   Other: Aqueous Cream B.P.;   Drug: Imiquimod;   Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Vietnam/1203/04 Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2018 Category: Research Source Type: clinical trials

Safety and Immunogenicity of Inactivated Influenza A/H5N1 Vaccine Administered With or Without Topical Aldara
Conditions:   Avian Influenza;   Influenza Immunisation Interventions:   Other: Aqueous Cream B.P.;   Drug: Imiquimod;   Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Vietnam/1203/04 Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2018 Category: Research Source Type: clinical trials

Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Inactivated Influenza A/H5N1 Vaccine Administered Intradermally With or Without Topical Aldara in Healthy Young Adults
Conditions:   Avian Influenza;   Influenza Immunisation Interventions:   Other: Aqueous Cream B.P.;   Drug: Imiquimod;   Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Vietnam/1203/04 Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2018 Category: Research Source Type: clinical trials

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
< b > Condition < /b > :   Avian Influenza < br/ > < b > Interventions < /b > :   Biological: aH5N1c;   Biological: Placebo < br/ > < b > Sponsors < /b > :   Seqirus;   Biomedical Advanced Research and Development Authority < br/ > < b > Recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2016 Category: Research Source Type: clinical trials